Transaction · 0001674236-26-000024

CAREY STEPHEN P.

CAREY STEPHEN P., SVP, CFO, reported an open-market or private sale at ANI PHARMACEUTICALS INC involving 2850.000000 shares for an estimated $208050.00. Reported holdings after the transaction were 168993.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SSVP, CFO
ANIPANI PHARMACEUTICALS INC
Filing timeSep 30
Trade dateSep 29, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded1.66%Shares sold ÷ (holdings after + shares sold). Estimated position before: 171,843 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$72.65
Pre-filing
1mo ago +0.2%1w ago +7.2%1d ago +3.0%
Returns since
7d30d90d180d1y

ANIP price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ANIP since 2026-09-30Filed today · pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001674236-26-000024
Common Stock
Transaction date
Sep 29, 2026
Filed Sep 30, 2026, 08:52 PM · 1d delay
Shares
2.85k sh
$73.00 per share
Estimated value
-$208k
Computed from shares × price
Holdings after
168k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

SVP & CFO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.

  2. F2

    The shares were sold in multiple trades at prices ranging from $72.57 to $73.86. The price reported above reflects the weighted average sales price.

Original filing · 0001674236-26-000024
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ANIP